Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shionogi
Pharma
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
China approved a first-in-class weight loss drug. Dizal won FDA approval. Biokin's BMS-partnered bispecific ADC celebrates a phase 3 win.
Angus Liu
Jul 10, 2025 5:20pm
Takeda, Enhertu, East Asian American execs—Fierce Pharma Asia
Jan 31, 2025 8:53am
Eisai, Takeda, BIOSECURE Act—Fierce Pharma Asia
May 17, 2024 8:30am
Shionogi's antiviral comes up short in global COVID-19 trial
May 13, 2024 10:48am
Orchid granted license to produce antibiotic to meet global need
Sep 12, 2023 9:55am
Shionogi, Takeda, AbbVie-BeiGene—Fierce Pharma Asia
Jun 30, 2023 9:45am
